Product Information
DESOGESTR-ETH ESTRAD ETH ESTRA is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1610 per EA under NDC 00378729653. Its NADAC has been published 624 times since Sep 10, 2014.
FDA first approved this application on Aug 30, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378729653
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202296FDA Approved
8/30/2013
TE Code
AB
On Market Since
7/16/2014
Price Statistics
The NADAC for DESOGESTR-ETH ESTRAD ETH ESTRA has been published 624 times since Sep 10, 2014, and over the history we have for it it has declined 84.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1610 per EA |
|---|---|
| All-time high | $1.0592 (Dec 10, 2014) |
| All-time low | $0.1319 (Apr 17, 2024) |
| 52-week high | $0.2029 |
| 52-week low | $0.1493 |
| Median price | $0.4454 |
| Average price | $0.4738 |
| Largest weekly change | +42.3% (Nov 22, 2023) |
| Weeks tracked | 624 |
| Tracking since | Sep 10, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the desogestrel and ethinyl estradiol and ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DESOGESTR-ETH ESTRAD ETH ESTRA?
The current National Average Drug Acquisition Cost (NADAC) for DESOGESTR-ETH ESTRAD ETH ESTRA, manufactured by Mylan Pharmaceuticals Inc., is $0.1610 per EA (NDC 00378729653), effective Aug 19, 2026.
How has the price of DESOGESTR-ETH ESTRAD ETH ESTRA changed over time?
Over the history we have for it, the NADAC for DESOGESTR-ETH ESTRAD ETH ESTRA has declined 84.2%. It has been tracked across 624 weekly CMS publications since Sep 10, 2014.
What are the highest and lowest recorded NADAC prices for DESOGESTR-ETH ESTRAD ETH ESTRA?
Since Sep 10, 2014, the NADAC for DESOGESTR-ETH ESTRAD ETH ESTRA has ranged from a low of $0.1319 (Apr 17, 2024) to a high of $1.0592 (Dec 10, 2014), with a median of $0.4454 per EA.
Are there cheaper alternatives to DESOGESTR-ETH ESTRAD ETH ESTRA?
No other NADAC-published product currently shares the active ingredient and strength of DESOGESTR-ETH ESTRAD ETH ESTRA in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DESOGESTR-ETH ESTRAD ETH ESTRA?
DESOGESTR-ETH ESTRAD ETH ESTRA (NDC 00378729653) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.